Thank you!
Your support is sustaining the future of local news in our communities.

COVID-19 Notebook: Myths and facts about the vaccination

COVID-19 Notebook: Myths and facts about the vaccination
The Boston Globe newspaper has shared content with other publications around the U.S. that is meant to reassure Americans that vaccines are safe. Photo Boston Globe

Last Tuesday, Aug. 18, the Boston Globe newspaper published a special section dedicated to reassuring Americans that COVID-19 vaccines are both safe and necessary. Other newspapers across the country were invited to take part and to share some of the Globe’s content. 

Because we are a weekly newspaper that comes out on Thursdays, we did not participate on the same day as other publications; but we share one of the stories, below, from the Boston Globe this week.

 

MYTH: The COVID-19 vaccines were developed too quickly to be safe.

FACTS: It’s understandable that people would have this concern. The vaccines were rolled out in record time, two of them using a novel technology. The government entity that led the effort was even called “Operation Warp Speed.”

But in reality, the mRNA technology behind the Pfizer and Moderna vaccines had been in development for nearly two decades, and a key feature of the technology is its ability to make vaccines quickly.

In testing the vaccines for safety and efficacy, no corners were cut. The same process was followed as with any vaccine, but to speed things up, drug companies performed different phases of the research simultaneously, instead of sequentially. Volunteers quickly signed up. And the drug manufacturers started making the vaccine even before they knew whether the vaccine would be authorized, so doses were ready right away.

In deciding to allow the vaccines for emergency use, the FDA had ample evidence from studies involving tens of thousands of volunteers. And in the months since, after millions have taken them, the vaccines have continued to demonstrate their safety and efficacy.

MYTH: COVID-19 vaccines alter people’s DNA.

FACTS: That rumor sprang up, most likely, because two of the vaccines use genetic methods that most of us don’t understand — the messenger RNA, or mRNA. But you don’t need a course in genetics to grasp this simple fact: The mRNA vaccine cannot affect your DNA because it never gets near it. It enters the cell, but has no access to the nucleus where the DNA is stored.

Instead, the mRNA instructs cells to make the coronavirus’s “spike protein,” which triggers the body to create antibodies. The mRNA quickly dissolves and so does the spike, but the body’s own antibodies remain, poised to attack the real coronavirus should it appear.

MYTH: COVID-19 vaccines can cause infertility.

FACTS: Not true. The rumor apparently emerged from another misunderstanding of human biology. An incorrect report on social media said that the spike protein on the coronavirus is the same as another spike protein involved with the growth of the placenta, falsely asserting that vaccines could attack the placenta. But that’s wrong. The two spike proteins are completely different, and the vaccine does not attack the placenta or affect fertility.

MYTH: COVID-19 vaccines contain mysterious ingredients that could have long-term effects.

FACTS: There’s no mystery. The ingredients in the vaccine are listed on the CDC’s website. They include typical vaccine ingredients, such as a fat capsule to protect the mRNA, salts and a little sugar. They do not include fetal lung tissue or microchips to track you. Those are conspiracy theories with no basis in fact.

In the rare cases when vaccines cause problems, they are identified within two months, usually within days.

MYTH: Young and healthy people are better off trusting their own immune systems than risking taking the vaccine.

FACTS: It’s important to weigh the risk of the vaccine against the risk of COVID-19.

Look at what’s happening around the country. COVID-19 is surging among unvaccinated people. In communities with low vaccination rates, thousands are getting sick and dying, and hospitals are running out of intensive care beds. Previously healthy young people have been put on ventilators and some have died. Many who survive COVID-19 — 10 percent to 30 percent — endure lingering symptoms, especially fatigue and mental fogginess that prevents them from working.

Compare that with the side effects of the vaccine. Some people feel a little feverish or tired for a day; most have no symptoms beyond a sore arm. Severe allergic reactions occur in one in 100,000 shots, but manifest instantly and can be quickly reversed with medication; that’s why you have to be observed for 15 minutes after inoculation.

The severe illnesses associated with COVID-19 vaccines — blood clots and heart inflammation — are extremely rare after vaccination. Both those conditions are much more likely to happen as a result of coronavirus infection.

And yes, it’s true that young healthy people often suffer only mild symptoms from COVID-19 (although, again, some do get very sick). But you don’t live alone on a tropical island, and even if you’re doing fine, you can infect someone else who won’t do well. Do you really want to be responsible for making a loved one or even a stranger deathly ill?

Nothing in life is risk-free. But COVID-19 vaccination is one clear case where the benefits far, far outweigh the risks.

Thanks to the Boston Globe for sharing their research

Latest News

At 95, Elyse Harney celebrated with Honorary Doctorate

Elyse Deublein Harney (center) celebrates with Keith Harney, Elyse Harney Morris, Paul Harney and Michael Harney after receiving an honorary doctorate from St. Joseph’s University.

Provided

On May 19, Elyse Deublein Harney returned to St. Joseph’s University in New York City, her alma mater, where she graduated in 1952. Before the crowd gathered for the university’s 107th commencement ceremony, the Salisbury resident, entrepreneur and community leader received an honorary doctorate and delivered the commencement address to the Class of 2026.

The recognition arrives at a meaningful moment for the Harney family. In February 2027, Elyse Harney Real Estate will celebrate its 40th anniversary, joining Harney & Sons Fine Teas, co-founded by Elyse and her husband, John, in 1983, as one of two enduring family businesses that have shaped both the region and the family’s legacy.

Keep ReadingShow less

The Renaissance spirit of Pilar Proffitt

The Renaissance spirit of Pilar Proffitt
The Renaissance spirit of Pilar Proffitt
The Renaissance spirit of Pilar Proffitt
Think logically and then break the mold with creativity.
— Pilar Proffitt

Pilar Proffitt is forging a remarkable artistic path grounded in her long history in Northwest Connecticut. Proffitt is a true Renaissance woman with a quirky sense of humor — a visual artist, architect, designer of interiors, furniture and products, and curator of home furnishings.

Her latest grand project is still quite literally under wraps. Large windows obscured by construction paper on a bustling avenue in Manhattan prevent passersby from peeking into the 15-story boutique hotel designed and furnished by Proffitt for an international hotel group, which is nearing completion. The hotel’s lobby, restaurant, common areas and rooms stand out for their attention to design — from the furnishings, colors and fabrics to the mosaic floor tiles, hardware, wrought-iron gates and stairs, selection of antique books, and the art on the walls. The collection includes paintings by Proffitt, photographs by Wassaic Project co-Executive Director Jeff Barnett-Winsby, time-lapse photography by Xan Padron and classics from the Warhol Factory.

Keep ReadingShow less
Take a trip to WWII England with the Sharon Playhouse’s ‘Swingtime Canteen’

The set for “Swingtime Canteen” transports the audience to WWII London.

D.H. Callahan

Dateline: 1944. A platoon of our boys are stationed in London, waiting to be sent to the mainland to fight the Axis powers and liberate Europe. While they wait, a group of glamorous gals from Hollywood are sent over to distract them with singing, dancing and a few memories of home.

That’s the scene at “Swingtime Canteen,” the new production now on stage at the Sharon Playhouse.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

A classical summer begins: eight Tanglewood picks

Aerial view of The Shed at Tanglewood.

Aram Boghosian

The Tanglewood classical music schedule is loaded with gems. Here are eight to consider:

Thursday, July 9, 8 p.m., in Ozawa Hall. The dynamic duo of Augustin Hadelich, violin, and Seong-Jin Cho, piano, take on works by Brahms, Janacek, Beach and Prokofiev. Whether you get seats in the hall or sit outside on the lawn, you will not regret getting to this one.

Keep ReadingShow less
Ken Musselman marks new chapter with farewell exhibition

Ken Mussleman with his paintings “Red Apple #2” and “Nine Servings Daily.”His show, “Time Passages,” opens Saturday, June 27, at Hunt Library in Falls Village.

L. Tomaino

Hunt Library in Falls Village will host a farewell show of the work of well-known local artist Ken Musselman, beginning with an opening reception on June 27 from 5 to 7 p.m. The show will run until July 31.

Musselman, a longtime resident of the Northwest Corner, recently moved to Woodbury, Connecticut, where he will begin a new phase of his life.

Keep ReadingShow less
Bugs! crawl their way into Upstate Art Weekend

“Butterfly in the Stomach” by Hanna Washburn at “Bugs!” part of Upstate Art Weekend.

Provided

Artist and curator Charlotte Woolf thinks bugs get a bad rap. Her new multimedium show at Foxtrot Farm and Flowers in Stanfordville seeks to change how people see these creepy-crawly creatures.

This time of year, there’s no way to escape the onslaught on bugs closing in from the wild. The little flyers and crawlers somehow penetrate even the tightest window screens. If there’s a crack in a floor board, it might as well have a big neon “Enter” sign. Like zombies from “Night of the Living Dead,” they approach with dispassionate determination.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.